相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine
R. Kaddurah-Daouk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
A Pharmacometabonomic Approach To Predicting Metabolic Phenotypes and Pharmacokinetic Parameters of Atorvastatin in Healthy Volunteers
Qing Huang et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Time for one-person trials
Nicholas J. Schork
NATURE (2015)
Plasma metabolomic profiles enhance precision medicine for volunteers of normal health
Lining Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Precision High-Throughput Proton NMR Spectroscopy of Human Urine, Serum, and Plasma for Large-Scale Metabolic Phenotyping
Anthony C. Dona et al.
ANALYTICAL CHEMISTRY (2014)
Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug Reactions
Munir Pirmohamed
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 15 (2014)
Pharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology
R. Kaddurah-Daouk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
A Pharmaco-Metabonomic Study on Chronic Kidney Disease and Therapeutic Effect of Ergone by UPLC-QTOF/HDMS
Ying-Yong Zhao et al.
PLOS ONE (2014)
Detection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomics
Jessica Tay-Sontheimer et al.
PHARMACOGENOMICS (2014)
Factors affecting the development of adverse drug reactions (Review article)
Muaed Jamal Alomar
SAUDI PHARMACEUTICAL JOURNAL (2014)
Pharmacogenomics: Current State-of-the-Art
Daniel F. Carr et al.
GENES (2014)
A novel untargeted metabolomics correlation-based network analysis incorporating human metabolic reconstructions
Helen L. Kotze et al.
BMC SYSTEMS BIOLOGY (2013)
Systems Pharmacology for Drug Discovery and Development: Paradigm Shift or Flash in the Pan?
P. Vicini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Purine Pathway Implicated in Mechanism of Resistance to Aspirin Therapy: Pharmacometabolomics-Informed Pharmacogenomics
L. M. Yerges-Armstrong et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance
K-H Shin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Cometabolism of Microbes and Host: Implications for Drug Metabolism and Drug-Induced Toxicity
H. Li et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Pharmacometabolomics of Statin Response
R. M. Krauss et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations
Abdul-Hamid M. Emwas et al.
METABOLOMICS (2013)
Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder - Possible Role for Methoxyindole Pathway
Hongjie Zhu et al.
PLOS ONE (2013)
Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo
R. Kaddurah-Daouk et al.
TRANSLATIONAL PSYCHIATRY (2013)
Alterations in metabolic pathways and networks in Alzheimer's disease
R. Kaddurah-Daouk et al.
TRANSLATIONAL PSYCHIATRY (2013)
Statistical methods for the analysis of high-throughput metabolomics data
Joerg Bartel et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2013)
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
Joerg Koenig et al.
PHARMACOLOGICAL REVIEWS (2013)
Covariate Pharmacokinetic Model Building in Oncology and its Potential Clinical Relevance
Markus Joerger
AAPS JOURNAL (2012)
Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy
Jeremy K. Nicholson et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment
Miles Trupp et al.
PLOS ONE (2012)
Understanding the time course of pharmacological effect: a PKPD approach
Daniel F. B. Wright et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Pharmacometabonomic Profiling as a Predictor of Toxicity in Patients with Inoperable Colorectal Cancer Treated with Capecitabine
Alexandra Backshall et al.
CLINICAL CANCER RESEARCH (2011)
Pharmacodynamic-Pharmacokinetic Integration as a Guide to Medicinal Chemistry
Johan Gabrielsson et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia
Ruth Condray et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Prediction of Variability in CYP3A4 Induction Using a Combined 1H NMR Metabonomics and Targeted UPLC-MS Approach
Nilufer Rahmioglu et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Metabolic phenotyping for monitoring surgical patients
James M. Kinross et al.
LANCET (2011)
Human metabolic individuality in biomedical and pharmaceutical research
Karsten Suhre et al.
NATURE (2011)
Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
Rima Kaddurah-Daouk et al.
PLOS ONE (2011)
Pharmacometabonomics as an effector for personalized medicine
Jeremy K. Nicholson et al.
PHARMACOGENOMICS (2011)
Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept
R. Kaddurah-Daouk et al.
TRANSLATIONAL PSYCHIATRY (2011)
An Integrative Approach for Identifying a Metabolic Phenotype Predictive of Individualized Pharmacokinetics of Tacrolimus
P. B. Phapale et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia
J. K. Yao et al.
MOLECULAR PSYCHIATRY (2010)
Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study
Rima Kaddurah-Daouk et al.
METABOLOMICS (2010)
Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy
Hector C. Keun et al.
CLINICAL CANCER RESEARCH (2009)
Individual Human Phenotypes in Metabolic Space and Time
Patrizia Bernini et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
Metabolomics tools for identifying biomarkers for neuropsychiatric diseases
Marlon P. Quinones et al.
NEUROBIOLOGY OF DISEASE (2009)
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism
T. Andrew Clayton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Metabolomics: A global biochemical approach to drug response and disease
Rima Kaddurah-Daouk et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Correlation network analysis for data integration and biomarker selection
Aram Adourian et al.
MOLECULAR BIOSYSTEMS (2008)
Metabolomic mapping of atypical antipsychotic effects in schizophrenia
R. Kaddurah-Daouk et al.
MOLECULAR PSYCHIATRY (2007)
Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st Century
Laura K. Schnackenberg
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2007)
LC-MS-based metabolomics in drug metabolism
Chi Chen et al.
DRUG METABOLISM REVIEWS (2007)
Metabolomics-based systems biology and personalized medicine: moving towards n=1 clinical trials?
Jan van der Greef et al.
PHARMACOGENOMICS (2006)
Pharmaco-metabonomic phenotyping and personalized drug treatment
TA Clayton et al.
NATURE (2006)
Implications of genetic polymorphisms in drug transporters for pharmacotherapy
R Kerb
CANCER LETTERS (2006)
Metabonomics techniques and applications to pharmaceutical research & development
JC Lindon et al.
PHARMACEUTICAL RESEARCH (2006)
Innovation -: Rescuing drug discovery:: in vivo systems pathology and systems pharmacology
J van der Greef et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Mechanism-based pharmacokinetic-pharmacodynamic modeling - A new classification of biomarkers
M Danhof et al.
PHARMACEUTICAL RESEARCH (2005)
A convenient five-drug cocktail for the assessment of major drug metabolizing enzymes:: a pilot study
A Sharma et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Innovation - Metabolite profiling: from diagnostics to systems biology
AR Fernie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Moving towards individualized medicine with pharmacogenomics
WE Evans et al.
NATURE (2004)
Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects
WE Evans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Genomic medicine - Inheritance and drug response.
R Weinshilboum
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
